<sentences><s id="0">A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell <e id="UMLS:C0024109:T023:ANAT">lung</e> cancer.</s>
<s id="1">The identification of patients who are at high risk for irinotecan-related severe diarrhea and <e id="UMLS:C0027947:T047:DISO">neutropenia</e> is clinically important.</s> <s id="2">We conducted the first genome-wide association study (GWAS) to search for novel susceptibility genes for irinotecan-related severe toxicities, such as diarrhea and <e id="UMLS:C0027947:T047:DISO">neutropenia</e>, in non-small-cell <e id="UMLS:C0024109:T023:ANAT">lung</e> cancer (NSCLC) patients treated with irinotecan chemotherapy.</s> <s id="3">The GWAS putatively identified 49 single-nucleotide polymorphisms (SNPs) associated with grade 3 diarrhea (G3D) and 32 SNPs associated with grade 4 <e id="UMLS:C0027947:T047:DISO">neutropenia</e> (G4N).</s> <s id="4">In the replication series, the SNPs rs1517114 (<e id="UNIPROT:Q49A92:T116:PRGE">C8orf34</e>), rs1661167 (FLJ41856) and rs2745761 (PLCB1) were confirmed as being associated with G3D, whereas <e id="UNIPROT:Q9UPQ7:T116:PRGE">rs11128347 (PDZRN3)</e> and rs11979430 and rs7779029 (SEMAC3) were confirmed as being associated with G4N.</s> <s id="5">The final imputation analysis of our GWAS and replication study showed significant overlaps of association signals within these novel variants.</s> <s id="6">This GWAS screen, along with subsequent validation and imputation analysis, identified novel SNPs associated with irinotecan-related severe toxicities.The Pharmacogenomics Journal advance online publication, 5 June 2012; doi:10.1038/tpj.2012.24.</s></sentences>